QIAGEN 24/31 CVQIAGEN 24/31 CVQIAGEN 24/31 CV

QIAGEN 24/31 CV

No trades
See on Supercharts

A3L06J analysis



Key facts


Issuer
Issue date
Sep 10, 2024
Maturity date
Sep 10, 2031
Outstanding amount
‪500.00 M‬USD
Face value
200,000.00USD
Minimum denomination
200,000.00USD
Coupon
2.50% (Fixed)
Yield to maturity
2.72%
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.